Arias E 2017 Methods to study chaperone-mediated autophagy. Methods Enzymol. 588 283–305

CAS  Article  Google Scholar 

Bhatt HB and Smith RJ 2015 Fatty liver disease in diabetes mellitus. Hepatobiliary Surg. Nutr. 4 101–108

PubMed  PubMed Central  Google Scholar 

Bluemel S, Williams B, Knight R and Schnabl B 2016 Precision medicine in alcoholic and nonalcoholic fatty liver disease via modulating the gut microbiota. Am. J. Physiol. Gastrointest. Liver Physiol. 311 G1018–G1036

Article  Google Scholar 

Chen YF, Liu H, Luo XJ, et al. 2017 The roles of reactive oxygen species (ROS) and autophagy in the survival and death of leukemia cells. Crit. Rev. Oncol. Hematol. 112 21–30

Article  Google Scholar 

Choi AMK, Ryter SW and Levine B 2013 Autophagy in human health and disease. N. Engl. J. Med. 368 1845–1846

CAS  Article  Google Scholar 

Czaja MJ, Ding WX, Donohue TM Jr, et al. 2013 Functions of autophagy in normal and diseased liver. Autophagy 9 1131–1158

CAS  Article  Google Scholar 

Farrell GC and Larter CZ 2006 Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43 S99–S112

CAS  Article  Google Scholar 

Fukuo Y, Yamashina S, Sonoue H, et al. 2014 Abnormality of autophagic function and cathepsin expression in the liver from patients with nonalcoholic fatty liver disease. Hepatol. Res. 44 1026–1036

CAS  Article  Google Scholar 

Gong ZW, Tas E, Yakar S and Muzumdar R 2017 Hepatic lipid metabolism and nonalcoholic fatty liver disease in aging. Mol. Cell Endocrinol. 5 115–130

Article  Google Scholar 

Gonzalez-Rodriguez A, Mayoral R, Agar N, et al. 2014 Impaired autophagic flux is associated with increased endoplasmic reticulum stress during the development of NAFLD. Cell Death Dis. 5 e1179

Haga Y, Kanda T, Sasaki R, et al. 2015 Nonalcoholic fatty liver disease and hepatic cirrhosis: Comparison with viral hepatitis-associated steatosis. World J. Gastroenterol. 21 12989–12995

CAS  Article  Google Scholar 

Jacob JA, Mohammad Salmani JM, Jiang ZY, et al. 2017 Autophagy: An overview and its roles in cancer and obesity. Clin. Chim. Acta 468 85–89

CAS  Article  Google Scholar 

Jiang W, Guo MH and Hai X 2016 Hepatoprotective and antioxidant effects of lycopene on nonalcoholic fatty liver disease in rat. World J. Gastroenterol. 22 10180–10188

CAS  Article  Google Scholar 

Kang MK, Kang BH and Kim JH 2015 Nonalcoholic fatty liver disease is associated with the presence and morphology of subclinical coronary atherosclerosis. Yonsei Med. J. 56 1288–1295

Article  Google Scholar 

Kashima J, Shintani-Ishida K, Nakajima M, et al. 2014 Immunohistochemical study of the autophagy marker microtubule-associated protein 1 light chain 3 in normal and steatotic human livers. Hepatol. Res. 44 779–787

CAS  Article  Google Scholar 

Kwanten WJ, Martinet W, Michielsen PP and Francque SM 2014 Role of autophagy in the pathophysiology of nonalcoholic fatty liver disease: a controversial issue. World J. Gastroenterol. 20 7325–7338

Article  Google Scholar 

Rabinowitz JD and White E 2010 Autophagy and metabolism. Science 330 1344–1348

CAS  Article  Google Scholar 

LaBrecque DR, Abbas Z, Anania F, et al. 2014 World Gastroenterology Organisation global guidelines: Nonalcoholic fatty liver disease and nonalcoholic steatohepatitis. J. Clin. Gastroenterol. 48 467–473

Article  Google Scholar 

Singh R, Kaushik S, Wang YJ, et al. 2009 Autophagy regulates lipid metabolism. Nature 458 1131–1135

CAS  Article  Google Scholar 

Sinha-Hikim AP, Sinha-Hikim I and Friedman TC 2017 Connection of nicotine to diet-induced obesity and nonalcoholic fatty liver disease: cellular and mechanistic insights. Front. Endocrinol. 8 23

Article  Google Scholar 

Skop V, Cahová M, Papáčková Z, et al. 2012 Autophagy-lysosomal pathway is involved in lipid degradation in rat liver. Physiol. Res. 61 287–297

CAS  Article  Google Scholar 

Ueno T and Komatsu M 2017 Autophagy in the liver: functions in health and disease. Nat. Rev. Gastroenterol. Hepatol. 14 170–184

CAS  Article  Google Scholar 

Xiao J, Guo R, Fung ML, et al. 2013 Garlic-derived S-allylmercaptocysteine ameliorates nonalcoholic fatty liver disease in a rat model through inhibition of apoptosis and enhancing autophagy. Evid. Based Complement Alternat. Med. 2013 642920

Younossi ZM, Stepanova M, Afendy M, et al. 2011 Changes in the prevalence of the most common causes of chronic liver diseases in the United States from 1988 to 2008. Clin. Gastroenterol. Hepatol. 9 524–530

Article  Google Scholar